The MHRA has published a consultation on several areas of the EU Falsified Medicines Directive (FMD). The consultation focuses on the safety features where the UK has flexibility within the Delegated Act on how to implement and the options available.
The UK medicines supply chain is complex and this consultation is looking primarily at how to accommodate the Directive where medicines are supplied to the public from places other than directly from pharmacies e.g. hospices, schools, prisons, dentists and vets. The consultation also looks at options for sanctions and enforcement and explains the implications of Brexit.
The Royal Pharmaceutical Society will be responding to this consultation and we want to hear your views on it. If you would like to contribute to our response, please contact Aileen Bryson by 31 August.